🇺🇸 JYNNEOS in United States
31 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 31
Most-reported reactions
- Fatigue — 4 reports (12.9%)
- Back Pain — 3 reports (9.68%)
- Constipation — 3 reports (9.68%)
- Erectile Dysfunction — 3 reports (9.68%)
- Glucose-6-Phosphate Dehydrogenase Deficiency — 3 reports (9.68%)
- Hepatitis A — 3 reports (9.68%)
- Herpes Simplex — 3 reports (9.68%)
- Hyperglycaemia — 3 reports (9.68%)
- Insomnia — 3 reports (9.68%)
- Microalbuminuria — 3 reports (9.68%)
Other Immunology / Infectious Disease approved in United States
Frequently asked questions
Is JYNNEOS approved in United States?
JYNNEOS does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for JYNNEOS in United States?
Womack Army Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.